ROBERT R RUFFOLO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT R RUFFOLO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT R RUFFOLO. ROBERT R RUFFOLO is a Senior VP Wyeth Research in WYETH ($WYE) and a Director in Diffusion Pharmaceuticals Inc. ($DFFN) and a Director in Aridis Pharmaceuticals, Inc. ($ARDS) and a Director in Sigilon Therapeutics, Inc. ($SGTX).
Address: FIVE GIRALDA FARMS MADISON 07940 NJ
Companies in which ROBERT R RUFFOLO is an Insider
Aridis Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT R RUFFOLO: Director
Holdings: 0 shares
Latest Transaction: Aug 14 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Diffusion Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT R RUFFOLO: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2018
$DFFN Market Capitalization: $44.17M
$DFFN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sigilon Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT R RUFFOLO: Director
Holdings: 0 shares
Latest Transaction: Dec 07 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WYETH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT R RUFFOLO: Senior VP Wyeth Research
Holdings: 17,380 shares
Latest Transaction: Mar 07 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT R RUFFOLO
Sentiment: All, ARDS, DFFN, SGTX, WYE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 07 2020 | SGTX | Sigilon Therapeuti ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 18.00 | 8,888 | 159,984 | 8,888 | |
| Aug 14 2019 | ARDS | Aridis Pharmaceuti ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 8.39 | 35,000 | 293,650 | 42,791 | |
| Jun 18 2018 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 0.54 | 40,000 | 21,600 | 40,000 | |
| Jan 04 2018 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 1.18 | 25,000 | 29,500 | 25,000 | |
| Jul 13 2017 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 2.31 | 52,057 | 120,252 | 52,057 | |
| Mar 07 2005 | WYE | WYETH | RUFFOLO ROBERT R | Senior VP Wyeth Res ... | Payment of Exercise | F | 40.63 | 238 | 9,670 | 17,380 | 17.6 K to 17.4 K (-1.35 %) |
| Mar 07 2005 | WYE | WYETH | RUFFOLO ROBERT R | Senior VP Wyeth Res ... | Grant | A | 0.00 | 5,085 | 0 | 17,618 | 12.5 K to 17.6 K (+40.57 %) |